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Spin-labeled peptideAβ (16–35) is the hydrophobic central core of β-amyloid peptide, the main component of plaques found in the
brain tissue of Alzheimer's disease patients. Depending on the conditions present, β-amyloid peptides undergo a
conformational transition from random coil or α-helical monomers, to highly toxic β-sheet oligomers and
aggregate ﬁbrils. The behavior of β-amyloid peptide at plasma membrane level has been extensively investigated,
and membrane charge has been proved to be a key factor modulating its conformational properties. In the present
work we probed the conformational behavior of Aβ (16–35) in response to negative charge modiﬁcations of the
micelle surface. CD and NMR conformational analyses were performed in negatively charged pure SDS micelles
and in zwitterionic DPC micelles “doped” with small amounts of SDS. To analyze the tendency of Aβ (16–35) to
interact with these micellar systems, we performed EPR experiments on three spin-labeled analogues of Aβ (16–
35), bearing the methyl 3-(2,2,5,5-tetramethyl-1-oxypyrrolinyl) methanethiolsulfonate spin label at the N-
terminus, in the middle of the sequence and at the C-terminus, respectively. Our conformational data show that, by
varying the negative charge of the membrane, Aβ (16–35) undergoes a conformational transition from a soluble
helical–kink–helical structure, to a U-turn shaped conformation that resembles protoﬁbril models.precursor proteins; Boc, tert-
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Alzheimer's disease (AD) is a progressive neurodegenerative
disorder and is the most common cause of dementia in adults.
Mechanisms underlying this disease are still poorly understood,but the deposition of senile plaques composed of ﬁbrillar
aggregates of amyloid β peptide (Aβ) is a characteristic hallmark
of the pathology, and believed to play a fundamental role in
disease pathogenesis [1–4]. The formation of amyloid aggregates is
typical of numerous diseases: type 2 diabetes, Parkinson's disease,
Huntington's disease and Creutsfeldt–Jacob disease [5,6]. Therefore
the comprehension of the mechanism triggering the amyloid
misfolding aggregation is critical for the development of therapies
to treat all these diseases.
β-amyloid peptides are 39 to 43 amino acids long, derived
from the proteolytic cleavage of amyloid precursor proteins (APP) by
β- and γ-secretases. Aβ (1–40) and Aβ (1–42) are the main
components of plaques found in the brain tissue of AD patients
[7,8]. Depending on the conditions present, these peptides undergo a
conformational transition from random coil or α-helical monomers
to highly toxic β-sheet oligomers and aggregate ﬁbrils [9–11].
Aβ (16–35) corresponds to the hydrophobic core of the β-amyloid
peptide. It has been implicated in aggregation/disaggregation
processes and it is the focus of attention in the search for peptide or
peptidomimetic inhibitors of Aβ ﬁbrillation [12–14]. The structural
coordinates of β-amyloid ﬁbrils pertain to this portion of the peptide
[15]. In a recent model solved for Aβ (1–40) in complex with the
phage-display selected afﬁbody protein Z(Abeta3), [16] the hydro-
phobic core Aβ (17–36) was bound to the afﬁbody in a β-hairpin
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the β conformation [16].
In spite of a great deal of experimentation, the mechanisms
favoring the formation of amyloid aggregates are unclear. As β-
amyloid peptides are enzymatic products of the transmembrane
protein APP, the implication of plasma membrane in β-amyloid
conformational modiﬁcation have been extensively investigated.
Nevertheless, data collected up to now have been controversial and,
to some extent, contradictory, depending in many cases on the
methodology employed.
Increasing evidence, supported by experiments on several differ-
ent amyloidogenic proteins, show that the membrane surfaces may
act as a two-dimensional template for the formation of amyloid
nucleation seeds [17–21] forming the senile plaques that are
responsible for neuronal injury [22]. The structural behavior of non-
ﬁbril forming fragments of amiloidogenic proteins proved that plasma
membrane is able to enhance the tendency to form aggregate:
membrane surface may favor speciﬁc peptide secondary structures
orienting the exposition of the sites that, on the peptide surface, are
critical for the aggregation [23–29].
In a different hypothesis ﬁbril-formation is not the main mecha-
nism determining amyloid toxicity at membrane level. Instead of
mature amyloid ﬁbers, small oligomeric species of Aβ and other
amyloid proteins [30] may be responsible for membrane destabiliza-
tion, triggering the disruption of intracellular calcium homeostasis,
which is a central event in the pathogenesis [26–28]. The targeting of
compounds speciﬁcally to these oligomer toxic species, rather than to
the ﬁnal amyloid ﬁbers, may be effective at reducing the toxicity of
amyloidogenic proteins. Unfortunately, with the exception of few
successful applications of pulsed ﬁeld gradient (PFG) NMR spectros-
copy, [31] the analysis of earlier oligomeric species is generally
difﬁcult due to the experimental limitations in characterizing un-
stable heterogeneous mixtures that contain a wide range of molecular
sizes.
It is well known that the plasma membrane is an extremely
complex bio-system. To analyze the effect of single plasmamembrane
components on the structural behavior of Aβ peptides, many studies
have been carried out in membrane-mimicking models characterized
by different complexities and compositions. All of these data, acquired
with different biophysical techniques, point to the importance of
membrane charge as a key factor in modulating the conformation of
amyloid peptide and its ability to interact with themembrane surface.
Speciﬁcally, the release of encapsulated dyes, [32] shifts of lipid head
group, 31P nuclear magnetic resonances (NMRs), [33–35] changes in
bilayer ﬂuidity [36] and monolayer studies [37–39] indicate that the
structured Aβ is associated with anionic membranes. Aβ (1–40) binds
negative electrostatically charged membranes, positioning itself on
the outer envelope of the polar headgroup or in a transmembrane
position. This electrostatic interaction is essential to stabilize the Aβ
α-helical conformation and to prevent the release of the peptide from
producing toxic aggregates [40].
The experiments described above, employed sophisticated mem-
brane-mimicking models composed of highly compatible phospholi-
pids; nevertheless although biologically relevant, they do not provide
information at the atomic level regarding the structural changes of Aβ
in response to ﬁne adjustments of membrane charge.
High-resolution conformational data of Aβ peptide and its related
fragments in membrane-mimicking systems have been produced,
thanks to multidimensional NMR spectroscopy studies in detergent
micelle solutions [41–46]. These are biophysical systems widely
employed as lipid bilayermimetic media in NMR studies of membrane
proteins and polypeptides thanks to the rapid and effectively isotropic
reorientation of the protein which enable high quality NMR experi-
ments to be produced [47,48]. In reality, detergents are a more
dynamic environment than the native bilayer and may impart
ﬂexibility and instability to the solubilized membrane protein,possibly resulting in denaturation [49]. Therefore in the search for a
membrane mimetic micelle system, detergents able to preserve the
folding and the functionality of the protein should be selected. DPC
micelles are considered good model to mimic the phospholipid
membrane, since characterized by a headgroup identical to phospha-
tidylcholine, the most common lipid in animal cell membranes.
Several studies have shown that DPC preserve the native conforma-
tions of membrane-associated peptides and enzyme activity of
membrane proteins in some cases [50,51]. SDS are anionic detergents
producing negatively charged micelles. SDS is known as denaturant of
protein domains [52,53], but it is commonly employed in the
identiﬁcation of native helix–helix interactions in TM segments [54]
and in some instances, is able to maintain the native tertiary and
quaternary structure of membrane proteins that lack signiﬁcant
extramembranous domains [55].
SDS and DPC micelles have been used to solve the NMR structure
of full length Aβ peptide and its related fragments [41–46]. In SDS
micelle solution, Aβ (1–40) has been shown to assume an α-helical
structure within residues 15–24 and 28–36, having a kink or hinge
around residues G25–N27. The peptide has a bent shape and is
thought to be partly inserted into the micelle. In lithium dodecyl
sulfate (LiDS) or SDS micelles, the shorter fragments Aβ (12–28), Aβ
(25– 35) and Aβ (1–28) all form α-helical structures [44,45]. In pure
SDS and pure DPC lipid environments the interaction of Aβ (12–28)
with zwitterionic DPCmicelles was shown to be weak. In contrast, the
interaction of the peptide with anionic SDS micelles was strong [46].
Multidimensional NMR was used to analyze ganglioside–Aβ interac-
tions in SDS micelles and to study Italian and Flemish variants of Aβ
(11–28) [56–58].
SDS and DPC micelles are respectively characterized by strongly
negative and completely zwitterionic surfaces. Considering the
sensitivity of the Aβ peptide to membrane charge, we hypothesize
that a drastic change, from a strongly negative SDS surface to a
zwitterionic DPC surface, may not be necessary to induce conforma-
tional modiﬁcations of Aβ peptides. More moderate changes of charge
contents, such as those produced by mixed negatively charged and
zwitterionic detergent micelles, may be sufﬁcient. Mixtures of DPC
“doped” with small amounts of SDS are known to be efﬁcacious
toward modulating the charge distribution of the micelle surface [59].
Therefore, we undertook a comparative conformational study, by
means of CD and NMR spectroscopy, of the β-amyloid fragment Aβ
(16–35) in negatively charged pure SDS micelles and in DPC/SDS 90/
10 (w:w)mixedmicelles. The tendency of Aβ (16–35) to interact with
these micellar systems was analyzed by electron paramagnetic
resonance (EPR) spectroscopy [60]. In the present work, we
performed two complementary series of EPR experiments by
randomly including spin-labeled peptides and spin-labeled lipids in
micelle aggregates. Three spin-labeled analogues of Aβ (16–35),
bearing the MTSL spin label at the N-terminus, in the middle of
the sequence and at the C-terminus (Fig. 1), were synthesized
(see Experimental section) to monitor speciﬁc portions (N-terminus,
C-terminus and middle of the sequence) of Aβ (16–35) at the micelle
interface using EPR spectroscopy. The information obtained through
these experiments was combined with those derived from spin-
labeled micelles, yielding a detailed picture of Aβ (16–35)–micelle
interactions.
Our conformational data show that, by varying the content of
negative charges, Aβ (16–35) undergoes a conformational transition
from a soluble helical–kink–helical structure, which is similar to
others solved in analogue micelle systems, to a conformation that
resembles protoﬁbril models.
Interestingly, the Aβ (16–35) model in mixed micelles is similar
to the ﬁrst soluble strand–turn–strand conformation found for
Aβ (1–40) in the afﬁbody-complex. This conformational change
is also reﬂected in changes of peptide mobility at the membrane
interface.
Fig. 1. Aminoacid sequence of Aβ (16–35) (I), Aβ (16–35) bearing MTSL spin label at the C-terminus (II), in the middle of the sequence (III) and at the N-terminus (IV).
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of the full length Aβ (1–42), a critical region in the aggregation–
disaggregation processes, we can conclude that the solution struc-
tures of Aβ (16–35), in SDS pure micelles and in DPC/SDS mixed
micelles, may be more generally considered models of two Aβ
conformational states (soluble and protoﬁbrillar). These are poten-
tially useful as molecular targets in the search for molecules that act to
prevent and/or reverse ﬁbril aggregation.
2. Experimental section
2.1. Materials
The starting material for the synthesis of 5 (Scheme 1), 2,2,5,5-
tetramethyl-1-oxypyrroline-3-carboxylic acid, was purchased from
Acros Organics. Protected amino acids and chemicals were purchased
from Fluka. All other reagents and solvents were purchased from
Sigma-Aldrich. Dry solvents were distilled under nitrogen immedi-
ately prior to use. Tetrahydrofuran (THF) was distilled from Na/
benzophenone ketyl, while CH2Cl2 and triethylamine (TEA) were
distilled from CaH2. All intermediates (1–4) and the title compound
(5) were puriﬁed by ﬂash chromatography (silica gel 60, 230–
400 mesh, Merck) using a mixture of EtOAc/petroleum ether (90/10
for 1–4 and 65:35 for 5) as the eluent. Reaction and product mixtures
were routinely monitored by thin-layer chromatography (TLC) on
silica gel pre-coated F254 Merck plates. Melting points were taken on a
Gallenkamp melting point apparatus and were consistent with
previously reported values [61–65]. Mass spectra of compound 5and labeled peptides Aβ (16–35)-MTSLC-term, Aβ (16–35)G25C-MTSL
and Aβ (16–35)-MTSLN-term were obtained by electrospray ionization
(ESI).
2.2. Solid-phase peptide synthesis and puriﬁcation
Aβ (16–35) (K-L-V-F-F-A-E-D-V-G-S-N-K-G-A-I-I-G-L-M) and the
analogous II, III, and IV (Fig. 1) were synthesized according on a
manual batch synthesizer (PLS 4×4, Advanced ChemTech) using a
Teﬂon reactor (10 mL), applying the Fmoc/tBu solid phase peptide
synthesis (SPPS) procedure. The Wang resin was swelled with DMF
(1 mL/100 mg of resin) for 3 h before use.
Stepwise peptide assembly was performed by repeating for each
added amino acid the following deprotection–coupling cycle: 1)
Swelling: DMF (1 mL/100 mg of resin) for 5 min; 2) Fmoc-deprotec-
tion: resin is washed twice with 20% piperidine in DMF (1 mL/100 mg
of resin, one wash for 5 min followed by another wash for 20 min); 3)
Resin-washings: DMF (3×5 min); 4) Coupling: scale employing
HBTU/HOBt/NMM (2.5:2.5:3.5 eq.) as the coupling system and
2.5 eq. of the Fmoc protected amino acids. Each coupling was
monitored by Kaiser test43 and was negative, therefore recouplings
were not needed; 5) Resin-washings: DMF (3×5 min) and DCM
(1×5 min). After deprotection of the last NR-Fmoc group, the peptide
resin was washed with methanol and dried in vacuo to yield the
protected peptide-Wang-resin. The protected peptide was cleaved
from the resin by treatment with TFA/H2O/phenol/ethanedithiol/
thioanisole (reagent K) (82.5:5:5:2.5:5 v/v) at a ratio of 10 mL to 0.5 g
of resin at room temperature for 3 h. After ﬁltration of the exhausted
Scheme 1. Reagents and conditions: a) LiAlH4, dry THF, rt, overnight (40%);
b) CH3SO2Cl, dry CH2Cl2, TEA, rt, 3 h (76%); c) LiBr, dry acetone, reﬂux, 3 h (71%);
d) CH3SO2SNa, absolute EtOH, reﬂux, 4 h (80%).
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triturated with ether.
The crude peptidewas puriﬁed by preparative reversed phase high
performance liquid chromatography (HPLC) using a Jupiter [Phenom-
enex, Anzola Emeilia (BO), Italy] C18 column (25×4.6 cm, 5 μ, 300 Å
pore size). The columnwas perfused at a ﬂow rate of 3 mL/min with a
mobile phase containing solvent A (0.1% TFA in water). A linear
gradient from 50% to 90% of solvent B (acetonitrile in 0.1% TFA) for
40 min was adopted for peptide elution. The pure fraction was
collected to yield a white powder after lyophilization. The molecular
weight of the compound was determined by mass spectral analysis.
2.3. Mass spectral analysis
Peptide fragments were characterized using a Finnigan LCQ-Deca
ion trap instrument equipped with an electrospray source (LCQ Deca
Finnigan, San Jose, CA, USA). The samples were directly infused into
the ESI source using a syringe pump set at a ﬂow rate of 5 μl/min. Data
were analyzed with Xcalibur software.
2.3.1. Synthesis of spin-labelmethyl 3-(2,2,5,5-tetramethyl-1-oxypyrrolinyl)
methanethiolsulfonate (SLMTS)
Spin-label methyl 3-(2,2,5,5-tetramethyl-1-oxypyrrolinyl) metha-
nethiolsulfonate (SLMTS; 5) was synthesized as shown in Scheme 1.
According to previously reported procedures [44–47], alcohol 2 wasobtained by reduction with lithium aluminum hydride of commer-
cially available 2,2,5,5-tetramethyl-1-oxypyrroline-3-carboxylic acid
(1). Alcohol 2 was then reacted with methanesulfonyl chloride,
followed by treatment with lithium bromide, to give the bromo-
methyl derivative (4). Finally, nucleophilic substitution of 4 with
sodiummethanethiosulfonate afforded the title compound as a brown
solid in good yield.
2.4. Derivatization of Aβ (16–35) with MTSL
To insert MTSL on the Aβ (16–35) C-terminus, in the middle of
the sequence and at the N-terminus, Aβ (16–35) analogues were
synthesized. These included the Cys residue at C-, in the middle (M-)
and at the N-terminus to produce peptides II, III, and IV, respectively
(Fig. 1).
Crude peptides II, III, or IV (1 eq) in CH3CN/H2O (8:2; 4 mL) were
incubated with a 4-fold molar excess of (1-oxyl-2,2,5,5-tetramethyl-
pyrrolidin-3-yl)methyl methanethiosulfonate (5) in acetone (2 mL).
The resulting mixture was stirred at room temperature for 72 h.
Solvent was then removed by ﬁltration and the residue was washed
with ethyl ether until no appreciable amount of spin-label (4) was
detected with TLC (EtOAc/petroleum ether 65:35). The puriﬁcation of
labeled peptides, designated as Aβ (16–35)C-term or Aβ (16–35)N–
term, was achieved using a semi-preparative RP-HPLC C-18 bonded
silica column. Puriﬁed peptides were determined by mass spectral
analysis. Prior to EPR analysis, the peptides [Aβ (16–35)-MTSLC-term,
Aβ (16–35)G25C-MTSL, and Aβ (16–35)-MTSLN-term] were treated
with 10% aqueous ammonia (pH 9.5) for 4 h at room temperature, to
re-oxide the spin label back to the nitroxide form [66].
2.5. Sample preparation for CD and NMR analysis
Unstructured aggregates are often present in untreated samples
from synthesis experiments and can severely hamper solubility. To
disaggregate such material, which could have been present in the dry
peptide, all CD and NMR samples were treated with TFA immediately
before being dissolved in the ﬁnal mixture, as described by Jao et al.
[67].
To record CD and NMR experiments in water solution, Aβ (16–35)
that was previously treated according to the procedure reported
above, [67] was added to an aqueous solution (pH 5.4 phosphate
buffer). This yielded ﬁnal concentrations of 0.15 mM (CD experi-
ments) and 1.5 mM (NMR experiments). For NMR samples, a H2O/
D2O (90:10 v/v) mixture was used.
The samples for CD and NMR experiments in SDS micelles were
prepared by dissolving Aβ (16–35) peptide (0.15 mM for CD
experiments and 1.5 mM for NMR experiments) in a SDS/water
mixture. A concentration of 80 mM SDS was used, which is 10 times
higher than the SDS critical micellar concentration (cmc) [68]. The
ﬁnal pH was adjusted to 5.4 using 20 mM of phosphate buffer. For
NMR experiments, d25SDS was used.
Owing to solubility issues, SDS titrations were carried out for CD
and NMR studies in DPC/SDS mixed micelles. An appropriate amount
of Aβ (16–35) (see above) was dissolved in a DPC/H2O mixture. The
DPC concentration used was 27 mM (27 times higher than DPC cmc)
[68]. Subsequently, titration with SDS was carried out to cover the
molar DPC:SDS ratio of 90/10 (27 mM/3 mM) and to reproduce the
partial (2–3%) negative charge present in the typical membrane of
eukaryotic cells [69]. The ﬁnal pH was adjusted to 5.4 using 20 mM of
phosphate buffer. For NMR experiments, d25SDS and d38DPC were
used.
2.6. CD analysis
All CD spectra were recorded using a JASCO J810 spectropolari-
meter at room temperature and with a cell path length of 1 mm. CD
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to 190 nm, 1 nm band width, 4 accumulations, and 10 nm/min
scanning speed. Spectra were corrected for solvent contribution.
For an estimation of secondary structure content, CD spectra were
analyzed using the SELCONN algorithm from the DICHROWEBwebsite
[70,71].
2.7. NMR analysis
NMR spectra were collected using a Bruker DRX-600 spectrometer
at 300 K. One-dimensional (1D) NMR spectra were recorded in the
Fourier mode with quadrature detection. The water signal was
suppressed by low-power selective irradiation in the homo-gated
mode. DQF-COSY, TOCSY, and NOESY [72–74] experiments were run
in the phase-sensitive mode, using quadrature detection in ω1, via
time-proportional phase increases of the initial pulse. Data block sizes
were 2048 addresses in t2 and 512 equidistant t1 values. Prior to
Fourier transformation, the time domain data matrices were multi-
plied by shifted sin2 functions in both dimensions. A mixing time of
70 ms was used for the TOCSY experiments. NOESY experiments were
run with mixing times in the range of 100–250 ms. Qualitative and
quantitative analyses of DQF-COSY, TOCSY, and NOESY spectra were
achieved using SPARKY software [75].
2.8. Structure reﬁnement using molecular dynamics calculations
Peak volumeswere translated into upper distance boundswith the
CALIBA routine from the DYANA software package [76]. The requisite
pseudoatom corrections were applied for non-stereospeciﬁcally
assigned protons at prochiral centers and for the methyl group.
After discarding redundant and duplicated constraints, the ﬁnal list of
constraints (Table 1) was used to generate an ensemble of 100
structures by the standard DYANA protocol of simulated annealing in
torsion angle space implemented (using 6000 steps). No dihedral
angle restraints and no hydrogen bond restraints were applied. The
best 20 structures, which had low target function values (0.83–1.19)
and small residual violations (maximum violation=0.38 Å), were
reﬁned by in vacuo minimization in the AMBER 1991 force ﬁeld using
the SANDER program of the AMBER 5.0 suite [77,78]. To mimic the
effect of solvent screening, all net charges were reduced to 20% of
their real value. Moreover, a distance-dependent dielectric constant
(ε=r) was used. The cut-off for non-bonded interactions was 12 Å.
NMR-derived upper bounds were imposed as semi-parabolic penalty
functions, with force constants of 16 kcal/mol Å2. The function was
shifted to be linear when the violation exceeded 0.5 Å. The best 10Table 1
Structural statistics for the ﬁnal 20 structures Aβ (16–35) in SDS and in DPC/SDS
micelles.
PARAMETER Aβ(16–35) in
SDS micelles
Aβ(16–35) in
DPC/SDS micelles
RMSD from mean structure (Å) Peptide region
18–24 24–28 28–35 17–33
0.4285 0.5420 0.1343 0.5443
NOE distance restraints
Total 194 221
Intra 66 70
Short 83 90
Medium 45 59
Long 0 2
Ramachandran plot
Residues in most favored regions 56.3% 29.7%
Residues in additional allowed
regions
28% 47.3%
Residues in generously allowed
regions
14.7% 23%structures after minimization had AMBER energies ranging from
−441.4 to−391.1 kcal/mol. Final structures were analyzed using the
Insight 98.0 program (Molecular Simulations, San Diego, CA, USA).
2.9. EPR spectroscopy
Two series of EPR experiments were performed. For the former
experiment, spin-labeled peptides, including Aβ (16–35)-MTSLC-term,
Aβ (16–35)G25C-MTSL, or Aβ (16–35)-MTSLN-term (II, III, and IV,
respectively, in Fig. 1), were dissolved in the appropriate amount of
aqueous buffer or micellar solution to obtain a 0.2 mM peptide
concentration. The peptide/surfactant molar ratio was set to 1:100.
Thus, in these experiments, the effect ofmicelles on the EPR spectrumof
labeled peptideswas observed. In the latter series ofmeasurements, the
spinprobes 5-doxylstearic acid and16-doxylstearic acid (5-DSAand16-
DSA, respectively; Sigma) were inserted into micellar aggregates at a
1:100 probe/surfactant mole ratio (surfactant concentration 20 mM).
The effect of unlabeled peptides Aβ (16–35), at a 1:10 peptide/
surfactant mole ratio, on their EPR spectrum was monitored. In both
series of experiments, the sampleswere deoxygenated and successively
sealed in 1.00 mm i.d. quartz capillaries in a nitrogen atmosphere. EPR
spectra were obtained using a Bruker ELEXYS e500 X-band spectrom-
eter. Instrumental parameters were as follows: modulation amplitu-
de=0.16 G, to avoid signal over modulation; time constant=1.28 ms;
receiver gain=60 dB; and microwave power=2 mW (20 dB), to
prevent saturation effects. All measurements were performed at room
temperature.
3. Results
3.1. CD spectroscopy
The conformational preferences of Aβ (16–35) were preliminarily
screened by CD spectroscopy. Fig. 2 shows the CD spectra of Aβ (16–35)
recorded inwater, in pure SDSmicelles, and inDPC/SDSmixtures at 90/
10M/M(molar ratio). The CD spectrum recorded in aqueous solution at
pH 5.4 indicates the prevalence, in this medium, of disordered
structures. CD spectra of Aβ (16–35) acquired in pure SDS micelles
evidence positive ellipticity value at 198 nmand twominima at 208 and
222 nm, which are suggestive of helical conformations. CD spectra
recorded in DPC/SDS mixed micelle solutions showed a pronounced
negative ellipticity value at 218 nm. The quantitative evaluation ofFig. 2. CD spectra of Aβ(16–35) recorded in water, in pure SDSmicelles and in DPC/SDS
mixtures at 90/10 M/M.
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[70,71] interactive website (SELCONN algorithm), indicates that Aβ
(16–35) in water solution assumes random coil conformations with
minimal amounts of turn and strand structures. In pure SDS micelles,
this assumes 60% helical, 30% β-turn, and 10% random coil conforma-
tions. In mixed DPC/SDS micelles, Aβ (16–35) is present as 30% helical,
25% β-turn, 10% β-strand, and 35% random coil conformations.Fig. 4. NOE connectivities of Aβ(16–35) NOESY spectra in pure SDS micelles (top), and
in DPC/SDS 90/10 M/M mixed micelles (bottom).3.2. NMR spectroscopy
3.2.1. Chemical shift analysis
Awhole set of 1D and 2D proton spectra were recorded inwater, in
pure SDS micelles, and in mixed DPC/SDS micelles. To check the
absence of self-aggregation, spectra were acquired in the peptide
concentration range of 0.5–15 mM. No signiﬁcant changes were
observed in the distribution and shape of 1H resonances, indicating
that no aggregation phenomena occurred in this concentration range.
Complete assignments of the proton spectra of Aβ (16–35) in water
and micellar environments (see Supplementary material) were
achieved by the standard Wüthrich [79] procedure. Analysis of 2D
spectra was performed using the SPARKY software package [75].
Fig. 3 reports a graphical representation of the proton CHα
chemical shifts differences of Aβ (16–35) in SDS and DPC/SDS
micelles, and the CHα values of random coil peptides [79].
CHα chemical shifts are known to be diagnostic of peptide and
protein secondary structures. According to the Chemical Shift Index
(CSI), [80] groups of four (not necessarily consecutive) CHα showing
N0.1 ppm upﬁeld shifted values, as compared to random coil values,
are diagnostic of helix conformations. Regions characterized by non-
consecutive CHα values close or low-ﬁeld shifted, as compared, to the
CHα random coil values, are diagnostic of coil conformations [80]. In
agreement with this analysis, CHα chemical shift difference trends
were different overall for Aβ (16–35) in SDS and DPC/SDS micelle
solutions. This indicates a generally different secondary structure of
the peptide for the two micelle conditions. Numerous CHα upﬁeld
shifts for Aβ (16–35) in SDS demonstrate evidence for the appreciable
presence of peptides in turn–helical conformations. Whereas, CHα
chemical shift differences for Aβ (16–35) in DPC/SDS (90/10 M/M)
are diagnostic of low ordered structures. Speciﬁcally, the most
signiﬁcant divergences were observed for residues V24, G25, N27,
I31, and I32.Fig. 3. CHα chemical shifts differences of Aβ (16–35) in SDS (blue) and DPC/SDS (cyan) micelles, and the CHα values of random coil peptides.
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Fig. 4 shows the NOE connectivities of Aβ (16–35) NOESY spectra
inwater, in pure SDSmicelles, and in DPC/SDSmixedmicelles. Sporadic
sequential NH–NH(i, i+1), medium range CHα–CH2 β(i, i+3), and
CHα–NH(i, i+2) NOE effects were observed in the NOESY spectrum of
Aβ (16–35) in water. These involved, in particular, segment N27–L34,
suggesting the presence of a nascent helical structure in this portion of
thepeptide. The lackof regularNOEpatterns in the remainingpart of the
peptide suggests the absence of any regular secondary structure.
In pure SDS micelles, sequential NH–NH(i, i+1) effects involved
all residues of the L17–L34 sequence. Regular CHα–CH2 β(i, i+3)
were present in segments L17–G25 and K28–M35, respectively.
Additionally, sporadic CHα–NH(i, i+2) and NH–NH(i, i+2) NOE
effects were observed along different triads of the sequence.
In DPC/SDS mixed micelles, the NOE pattern was less regular, as
compared to that observed in SDS pure micelles. Several regular NH–
NH(i, i+1) and CHα–CH2 β(i, i+3) medium range connectivities
were observed.
The structural calculationsof Aβ (16–35) inwater, pure SDSmicelles,
andmixedDPC/SDSmicelleswere carriedoutusingDYANAsoftware on
the basis of NOE data. This data was transformed into interprotonic
distances and imposed as restraints in the calculation. Among 50
calculated structures, the resulting best twentywere selected according
to the lowest values of their target functions. They were subjected to
further minimization procedures with the SANDER module of AMBER
5.0 software, [77,78] using DYANA-derived restraints.
Fig. 5 showsNMR structure bundles of Aβ (16–35) in SDS andDPC/
SDS micelles. Statistical information for the structural ensemble of Aβ
(16–35) in water, SDS, and DPC/SDS micelles is shown in Table 1.
Analysis of the bundles, according to the PROCHECKNMR [81]
procedure, indicated that Aβ (16–35) NMR structures in water were
characterized by a turn-helical conformation on residues K28–M35.
Ramachandran plots of Aβ (16–35) NMR structures in pure SDS
micelles showed that the dihedral angles of different conformerswere
in good agreement and fell in allowed regions for residues L17–V24
and N27–M35 (Supplementary material). The scattering of dihedral
angles in residues G25 and S26 was evident, indicating high structural
ﬂexibility at this point of the sequence (see Supplementary material).
Analysis of the structure bundle, according to Kabsh and Sanders
parameters, points to the presence of regular α-helical and type I β-
turn conformations involving the residues F19–V24 and K28–I32,
respectively. The conformation of fragment F19–V24 was stabilized
by the presence of H-bonds involving NH A21 C O V18, NH E22 C O
F19, NH E22 C O F20, and NH D23 C O F19. On the other hand,Fig. 5. NMR structure bundles of Aβ (16–35) in SDS micelles (segment 17–25— orange; segment 28–34—orange red) and in DPC/SDS micelles 90/10 M/M (yellow).the conformation of segment 28–32 was stabilized by the presence of
H-bonds involving NH G29 C O N27 and NH I32 C O A30.
Ramachandran plots of Aβ (16–35) NMR structures in DPC/SDS
micelles (see Supplementary material) demonstrated evidence of a
general agreement among the dihedral angles of different conformers.
With the exception of those belonging to C-terminal residues L34 and
M35, all of them fall within allowed regions. For residues G25 and S26,
low scattering of the dihedral angles was evident, as compared to the
structures in pure SDS micelles. Evaluation of the structure bundle,
according to Kabsh and Sanders parameters, points to the presence of
regular type I β-turn structures, corresponding to the residues S24–
N27. Several conformers showed an extension of the turn structures
to segments F20–V24, or alternatively to K28–A30.
3.4. Complementary NMR and EPR spin-label aided studies
To investigate the positioning of Aβ (16–35) peptide relative to the
surface and interior of micelles, we performed EPR and NMR
experiments in the presence of spin-labeled substances (i.e. sub-
stances with unpaired electrons) [60,82,83]. We performed two
complementary series of EPR experiments. In the ﬁrst, spin-labeled
peptides (Fig. 1) were used, enabling us to monitor how the presence
of micelles affects peptide behavior. In the second series of
experiments, we used micellar aggregates randomly labeled via the
inclusion of small amounts of lipids bearing a radical group. In both
cases, cyclic nitroxides were used as spin labels due to their
remarkable stability and to the localization of the spin density on
the NO moiety, which allows to extract a great deal of information on
the label solubilization site from the EPR spectrum. Indeed, because of
the coupling between the electron spin and the nuclear spin of the
nitrogen atom, the EPR spectrum of a cyclic nitroxide presents three
lines (see Fig. 6). The spacing between them corresponds to the
nitrogen isotropic hyperﬁne coupling constant, AN, which increases
with the polarity of the medium in which the nitroxide is embedded.
Furthermore, a detailed analysis of the lines' amplitudes allows to
obtain the nitroxide correlation time, τC, which depends on the label
rotational mobility, as determined by the microenvironment viscosity
and/or by speciﬁc interactions. From a qualitative viewpoint, narrow
lines (low τC) indicate that the label is quite free to rotate, while broad
lines (high τC) indicate that the motional freedom is reduced.
Broadening is usuallymuchmore evident for the line at high ﬁeld [84].
Aβ (16–35) was properly spin-labeled at the C-terminus, in the
middle of the sequence (position 25), and at the N-terminus, to
produce Aβ (16–35)-MTSLC-term (II), Aβ (16–35)G25C-MTSL (III), and
Aβ (16–35)-MTSLN-term (IV), respectively (Fig. 1). EPR spectra of all
Fig. 6. Experimental (continuous line) and simulated (dotted line) EPR spectra of Aβ
(16–35), labeled at the C-terminus, in phosphate buffer (A) and in SDS solution (B).
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DPC/SDS (90:10) micellar solutions. In all cases, the expected three
hyperﬁne lines were observed. This is evidence that no peptide self-
aggregation took place. If thiswere the case, then spin–spin interactions
would have provoked the collapse of the three lines, i.e., the appearance
of a single very broad line [85].
Furthermore, in all the systems considered here, EPR spectra
showed narrow lines indicative of an isotropic fast motion. This is
despite the fact that a slight, but signiﬁcant broadening, due to the
interaction between spin-labeled peptides and micelles, was evident
(see spectrum B in Fig. 6 with respect to spectrum A). Consequently,
spectral analysis was carried out according to the classical theory of
motional narrowing for EPR lines [86].
AN and τC values for Aβ (16–35)-MTSLC-term (II), Aβ (16–35)G25C-
MTSL (III) and Aβ (16–35)-MTSLN-term (IV) in the various systems
analyzed in the present work are shown in Table 2.Table 2
Nitrogen coupling constant, AN, and spin label correlation time, τC, measured by EPR
experiments on either spin labeled Aβ (16–35) in phosphate buffer, SDS and DPC/SDS
micelles or doxyl stearic acids in SDS and DPC/SDS micelles, in the absence and in the
presence of Aβ (16–35).
AN/G τC×1010/s
Aβ (16–35)Cterm
phosphate buffer 16.19±0.02 1.8±0.2
SDS 15.32±0.02 3.3±0.3
DPC/SDS 90:10 16.10±0.02 3.2±0.3
Aβ (16–35)Nterm
phosphate buffer 16.20±0.02 1.7±0.2
SDS 15.81±0.02 2.8±0.3
DPC/SDS 90:10 15.68±0.02 3.1±0.3
Aβ (16–35)G25C-MTSL
phosphate buffer 16.21±0.02 1.7±0.2
SDS 15.26±0.02 3.7±0.3
DPC/SDS 90:10 15.92±0.02 4.2±0.3
5-DSA
SDS 15.07±0.04 17±2
SDS-Aβ (16–35) 14.96±0.04 28±3
DPC/SDS 90:10 14.48±0.04 27±3
DPC/SDS-Aβ (16–35) 14.39±0.04 30±3
16-DSA
SDS 15.15±0.04 6.7±0.6
SDS-Aβ (16–35) 15.09±0.04 12.8±1.3
DPC/SDS 90:10 14.68±0.04 10.5±1.0
DPC/SDS-Aβ (16–35) 14.74±0.04 10.7±1.1In phosphate buffer, no difference was found between values for
the three spin-labeled peptides. Thus, the environment in which the
nitroxide label is embedded did not depend on its positioning along
the peptide chain, indicating that the whole molecule was fully
exposed to the aqueous medium. Overall, signiﬁcant changes in the
EPR parameters, owing to the presence of SDS or DPC/SDS micelles,
were evident. Particularly, the τC value increased, a consequence of a
decrease in the label mobility. This evidence indicates peptide
interactions with the micellar aggregates to occur. The whole peptide
was involved in the interaction, as the three spin-labeled peptides
showed comparable τC changes, even though a slightly higher τC
increase was found for Aβ (16–35)G25C-MTSL.
At the same time, the decrease in AN indicates that spin labels were
embedded in a less polar microenvironment with respect to the
aqueous medium. Speciﬁcally, as far as DPC/SDS micelles are
considered, the extent of the AN reduction is quite low (from 0.1 to
0.5 G) for all the three spin-labeled peptides. A comparable AN
reduction was reported in the literature for labels whose solubiliza-
tion site in the micelles is just below the external hydrophilic layer
[87]. Consequently, our evidences suggest a shallow insertion of the
whole peptide in the mixed micellar aggregates (see Fig. 7 for a
schematic representation of peptide–micelle relative positioning). In
contrast, Aβ (16–35)-MTSLC-term (II) and Aβ (16–35)G25C-MTSL (III)
presented a more pronounced AN decrease in SDS micelles (∼1 G).
This suggests deep penetration of the second half of the Aβ (16–35)
sequence in the SDS micellar apolar core, with the N-terminus being
more exposed to the external medium (see Fig. 7).
To see whether the interaction with Aβ (16–35) inﬂuenced the
microstructure of SDS and DPC/SDS (90:10) micelles, we performed
EPR measurements on micellar solutions in the presence and absence
of the peptide. Spin labels used for this experiment were 5-
doxylstearic acid (5-DSA) and 16-doxylstearic acid (16-DSA). The
former provided information on the micellar layer just below the
external surface, while the latter gave information on the interior of
the micellar hydrophobic core. Spectroscopic parameters obtained
from these spectra are shown in Table 2. In both micellar systems, the
τC value was higher for 5-DSA than for 16-DSA. In other words, the
motion of 5-DSA was slower than for 16-DSA. This indicates a
ﬂexibility increase in segmental chain mobility when going from
surfactant polar headgroups to the inner hydrophobic core of micelles.
The presence of Aβ (16–35) caused signiﬁcant effects on SDSmicelles.
In fact, for both spin-labeled surfactants, τC signiﬁcantly increased.Fig. 7. Schematic representation of Aβ (16–35) orientation on SDS (left) and DPC/SDS
(right) micelles. The portion of Aβ (16–35) spanning from themiddle to the C-terminus
is partially embedded in SDS micelles (left). Embedding of Aβ (16–35) is reduced in
DPC/SDS, (right).
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of the peptide, or of a segment of it, into the micellar core, since the
local structuring of the alkyl chain tends to be more ordered in
proximity of a guest molecule [88]. In contrast, the spectra of both
spin labels in DPC/SDS mixed micelles were almost unaffected by the
presence of Aβ (16–35), indicating no signiﬁcant insertion of the
peptide into the micelle interior. Thus, evidences obtained using spin-
labeled lipids are in perfect agreement with those obtained with spin-
labeled peptides, and support the peptide–micelle relative positioning
proposed in Fig. 7.
To conﬁrm EPR data, NMR experiments were recorded in micelle
solutions containing 5-DSA or 16-DSA. Paramagnetic probes are able
to induce a broadening of the NMR signals and a decrease in
resonance intensities. Generally, the sites of the peptide which are
close to the NO moiety are affected by the unpaired electrons with an
increase in nuclear relaxation rates and, thus, a decrease in proton
signals. If the peptide is close to the surface or penetrates the inner
core of the micelle, a decrease in intensity is observed in 5-DSA spin-
labeled micelles or in 16 DSA spin-labeled micelles, respectively [59].
1D and 2D TOCSY spectra of the Aβ (16–35) were recorded in pure
SDS micelles in the presence and absence of 5-DSA and 16-DSA,
keeping all other conditions constant. A comparison of TOCSY spectra
shows an unspeciﬁc modiﬁcation of CHα-NH cross peaks when Aβ
(16–35) was solved in DPC/SDSmicelles containing 5-DSA or 16-DSA.
In SDS micelles, a selective perturbation of CHα-NH TOCSY signals
were observed in the presence of 5-DSA spin labels, where a decrease
of signals relative to K28–M35 residues was evident.4. Discussion
A great deal of evidence implicates the plasma membrane in
processes leading to the misfolding and aggregation of β-amyloid
peptides. Accordingly, Aβ peptides have been extensively analyzed in
membrane-mimicking systems that are characterized by different
complexities and compositions.
Although all evidence shows that membrane charge is a critical factor
inmodulating the conformational behavior of amyloidpeptides, the exact
deﬁnition for the role of charge in affecting conformations of amyloid
peptide is controversial. Some data suggest that net negative charge is
essential in favoring the presence of peptide monomers. Some others
indicate that negatively chargedmembranes could catalyze the transition
of Aβ peptide to β-conformation and aggregation [17–20,22,40].
Micellar aggregates are extremely simpliﬁed models of biological
membranes. Nevertheless, they offer the advantage of enabling high-
resolution NMR solution studies. This is thanks to the rapid and
effectively isotropic reorientation of the protein [47].Fig. 8.U-turn shaped structural motif of Aβ (16–35) in DPC/SDSmixedmicelles (centre) as co
2OTK) and Aβ (1–40) in protoﬁbril models (right).
(Luhrs et al. 2005; PDB id: 2BEG).High-resolution structures of Aβ peptide, in strongly negative
charged SDS micelles and in zwitterionic DPC micelles, have been
solved using NMR spectroscopy [41–46]. Mixtures of DPC “doped”with
small amounts of SDS may be used to modulate the charge distribution
of the micelle surface.
In the present work we probed the conformational behavior of Aβ
(16–35) in response to negative charge modiﬁcations of the micelle
surface. Toward this end, we performed solution spectroscopic studies
of the amyloid fragment Aβ (16–35) in pure SDS micelles and in
mixed DPC/SDS 90/10 w:w micelles.
Aβ (16–35) represents the hydrophobic central part of β-amyloid
peptide, being implicated in aggregation/disaggregation processes. In
ﬁbril structural models, [15] it represents the repetitive unit of β-
amyloid peptide aggregates. In a recent search for amyloid antibodies,
this fragment was found to be speciﬁcally linked to antibodies [16]. In
spite of the numerous structural studies made on several different
fragments of β-amyloid peptides [41–46] with the exception of a
computational study that demonstrated the structural importance of a
salt bridge between D23 and K28, [89] data on the Aβ (16–35)
structure has not been available until now.
Results presented here show that Aβ (16–35) in SDS micelles
assumed regular α-helical and type I β-turn conformations involving
the residues L17–D23 and G29–L34, respectively. Segment V24–K28
was highly ﬂexible, as evidenced by scattering of the dihedral angles
of residues G25 and S26. Thus, the two turn-helical pieces were free to
vary their reciprocal orientation. Addition of zwitterionic surfactant to
produce DPC/SDSmixedmicelles, induced a decrease in L17–D23 and
G29–M35 structural regularity and a tightening of the V24–K28
segment. Most of the Aβ (16–35) NMR structures in DPC/SDSmicelles
were characterized by regular type I β-turns in V24–K28. From this
portion, regular turn structures alternatively span the N- or C-terminus
of the peptide.
Previous conformational studies have shown that amyloid pep-
tides in SDS micelles [41–43] and in water/ﬂuorinated solvent
mixtures [90,91] exhibit N and C-terminal turn-helical structures.
Their reciprocal orientation is regulated by the ﬂexible kink of V24-
K28.On the other hand, according to computational models [89] of Aβ
(16–35), solid-state NMR analyses for Aβ (9–40) peptides [92], and
H–D exchange NMR-based Aβ (17–42) protoﬁbril structures, [15]
amyloid peptides in the protoﬁbril are organized in two ordered β-
strands, with a connecting loop having an intramolecular salt bridge
between residues D23 and K28. Remarkably, both computational and
experimental models agree that the structure has a U-turn shape,
even if eachmodel proposes a distinct structure for the turn. Currently
there is increasing evidence [93–95] that the U-shaped ‘β-strand–
loop–β-strand’ motif observed in the Aβ organization is generally
applicable to all amyloids, including β2-microglobulin [94] and humanmpared to U-turn shaped Aβ (1–40) afﬁbody-complex (left) (Hoyer et al. 2008; PDB id:
Fig. 9. Schematic representation of Aβ (16–35) conformational transition from helical–
kink–helical structure, to U-Turn shaped conformation resembling protoﬁbril models.
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of the structure of Aβ (1–40) complexed to an Az3 afﬁbody was
carried out [16]. This demonstrated that the portion of Aβ (1–40) that
is linked to the afﬁbody protein corresponds to an Aβ (16–35)
fragment and is arranged in a β-hairpin structure.
The structure of Aβ (16–35) in SDS micelles, as found in the
present work, resembles others solved in the same conditions.
Consistently, we observed high solubility and structural organization.
In SDS micelles, a helix–turn–helix was found with high ﬂexibility of
kink peptide. Here the regularity of the conformations at the N and C-
terminus and the ﬂexibility of the hinge guarantee the solubility of the
fragment and stabilization of peptide monomers.
Aβ (16–35) in DPC/SDS micelles exhibited the U-turn shaped
structural motif that has been observed in protoﬁbril models and is
typical of all amyloid conformations (Fig. 8) [93–95]. In these
conditions, the structural compactness of C- and N-terminal helices
was lost and the tightening of the 24VGSNK28 kink segment favored
intramolecular and intermolecular contacts. This potentially could
lead to aggregation through inter-stands, with intermolecular con-
tacts between. In a similar manner to the conformation of the Aβ (1–
40) afﬁbody-complex, this is an example of an Aβ fragment in soluble
form that has the U-turn shape of protoﬁbrils.
Results derived from EPR experiments using MTSL spin-labeled
peptide provided additional elements to interpret our conformational
ﬁndings. Spin-label aided experiments demonstrated that the portion
of Aβ (16–35) spanning from the middle to the C-terminus was
partially embedded in SDS micelles (see Fig. 7). This effect can be
promoted by the electrostatic attraction mediated via the positively
charged 28 K with the sulphate of the surfactants. In these conditions,
the salt bridge between D23 and K28 — which is considered a
structural peculiarity of Aβ peptides in ﬁbril models- and conse-
quently the spatial contacts between the two termini are hampered.
On the contrary, in DPC/SDS, a minor electrostatic attraction is
plausible. Thus, embedding of the peptide in the micelle interior is
reduced and the intramolecular and possibly intermolecular interac-
tions between the C- and N-terminal segments are favored.
Interestingly EPR spectra revealed a higher increase in correlation
time, i.e., a stronger reduction of the label rotational mobility, for Aβ
(16–35)G25C-MTSL in DPC/SDS mixed micelles. This evidence,
together with the decrease in ﬂexibility observed for Aβ (16–35) in
DPC/SDS, depicts a conformational state that may be preliminary to
aggregation. (Fig. 9).
Thus, we speculated that the conformations in DPC/SDS presented
here constitute intermediate conformations on the pathway to
amyloid ﬁbrils. Decreasing charge results in tightening of the V24–K28 kink, and the concomitant destabilization of turn-helical pieces.
These events are strategic to move toward a strand–turn–strand
conformation, which is the milestone of amyloid aggregates.
The poor solubility of amyloid aggregates in the media normally
used for the biological tests hampers an extensive experimentation of
molecules potentially active as preventing and/or reversing of ﬁbril
aggregation. Interestingly our structure in DPC/SDS micelle can be
viewed as soluble form of U-turn shaped β-amyloid protoﬁbrils, that
can be a promising target to test new anti-Alzheimer agents.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamem.2009.12.012.
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